LynxsurfBio (LSB) is building a blood-based screening platform for dementia. With a akin handheld device akin to a glucometer connected to an AI analytics platform, LSB’s vision is to provide real-time clinical decision support based on an easy blood test of a person’s neurological health for early diagnosis and personalized treatment adaptation. We see the future where such accessible ‘glucometer’ for dementia can be integrated as part of the standard place of care flow in doctor’s offices, clinics, long term care facilities and local pharmacies.